NEUMORA THERAPEUTICS, INC.

Press Releases Neumora Therapeutics, Inc.

Equities

NMRA

US6409791000

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
9.95 ^USD	+0.20%		+0.51%	-41.64%

May. 14	Transcript : Neumora Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:00 AM
May. 14	Neumora Therapeutics Begins Phase 2 Study of Navacaprant in Bipolar Depression	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression	May. 14	AQ
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	May. 07	AQ
Neumora Therapeutics to Participate in Upcoming Conferences in May	May. 06	AQ
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study	Apr. 15	AQ
Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days	Mar. 13	AQ
Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	Mar. 07	AQ
Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer	Jan. 22	AQ
Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference	Jan. 02	AQ
Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer	Dec. 12	AQ
Vanderbilt University: Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial	Dec. 05	AQ
Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study	Nov. 27	AQ
Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update	Nov. 01	AQ
Neumora Therapeutics to Participate in Upcoming Conferences in November	23-10-30	AQ
Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development	23-10-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer